Skip to main content

Advertisement

SpringerLink
Log in

Interferon-α2b-induced STAT3 suppression in myeloid-derived suppressor cells in mycosis fungoides

  • Letter to the Editors
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

The Original Article was published on 24 March 2018

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Pileri A, Agostinelli C, Quaglino P, Patrizi A, Pimpinelli N (2018) The role of myeloid derived suppressor cell in mycosis fungoides: a commentary. Cancer Immunol Immunother. https://doi.org/10.1007/s00262-018-2153-9

    Article  PubMed  Google Scholar 

  2. Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9(3):162–174. https://doi.org/10.1038/nri2506

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Blank VC, Pena C, Roguin LP (2010) STAT1, STAT3 and p38MAPK are involved in the apoptotic effect induced by a chimeric cyclic interferon-alpha2b peptide. Exp Cell Res 316(4):603–614. https://doi.org/10.1016/j.yexcr.2009.11.016

    Article  PubMed  CAS  Google Scholar 

  4. Geskin LJ, Akilov OE, Kwon S, Schowalter M, Watkins S, Whiteside TL, Butterfield LH, Falo LD Jr (2018) Therapeutic reduction of cell-mediated immunosuppression in mycosis fungoides and Sézary syndrome. Cancer Immunol Immunother 67(3):423–434. https://doi.org/10.1007/s00262-017-2090-z

    Article  PubMed  CAS  Google Scholar 

Download references

Funding

This work was supported by Research Center Grants for Specialized Programs of Research Excellence of (P50CA121973) of National Institute of Health, Clinical and Translational Science and M01 Award of National Center for Research Resources.

Author information

Authors and Affiliations

  1. Department of Dermatology, University of Pittsburgh, Pittsburgh, PA, USA

    Larisa J. Geskin, Oleg E. Akilov, Michael K. Schowalter & Louis D. Falo Jr.

  2. Department of Dermatology, Columbia University, New York, NY, USA

    Larisa J. Geskin

Authors
  1. Larisa J. Geskin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Oleg E. Akilov
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael K. Schowalter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Louis D. Falo Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Louis D. Falo Jr..

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Additional information

This reply refers to the article available at https://doi.org/10.1007/s00262-018-2153-9.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Geskin, L.J., Akilov, O.E., Schowalter, M.K. et al. Interferon-α2b-induced STAT3 suppression in myeloid-derived suppressor cells in mycosis fungoides. Cancer Immunol Immunother 67, 1177–1178 (2018). https://doi.org/10.1007/s00262-018-2156-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00262-018-2156-6

Search

Navigation